Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled time : 15:40 save search
Iterum Therapeutics Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published: 2020-06-03 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -0.62%
H: 2.48%
C: -7.45%
offering nasdaq
Iterum Therapeutics plc Announces Result of Proposal 8 at Annual General Meeting
Published: 2020-06-15 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -1.95%
H: 3.17%
C: -0.66%
Iterum Therapeutics Announces Topline Results from its Phase 3 Clinical Trial of Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections
Published: 2020-06-29 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -4.58%
H: 0.68%
C: -2.74%
results phase 3 trial sulopenem treatment topline injection infections
Iterum Therapeutics Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Published: 2020-06-30 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -7.75%
H: 3.82%
C: -9.16%
offering nasdaq
Iterum Therapeutics Informs Shareholders of Record Date for Planned Rights Offering
Published: 2020-07-13 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -11.5%
H: 3.0%
C: 0.0%
offering
Iterum Therapeutics Reports Second Quarter 2020 Financial Results
Published: 2020-08-06 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -0.96%
H: 1.94%
C: 0.67%
results therapeutics
Iterum Therapeutics Commences Rights Offering
Published: 2020-08-11 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: -3.43%
offering therapeutics
Iterum Therapeutics Announces Expiration and Preliminary Results of Rights Offering
Published: 2020-09-01 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -2.56%
H: 3.16%
C: -3.95%
offering results therapeutics
Iterum Therapeutics Announces Revised Results of Rights Offering
Published: 2020-09-02 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -2.6%
H: 1.27%
C: -4.51%
offering results therapeutics
Iterum Therapeutics to Present at the 22nd Annual H.C. Wainwright Global Investment Conference
Published: 2020-09-08 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -1.15%
H: 5.09%
C: 4.9%
Iterum Therapeutics Announces Positive Pre-NDA Meeting with FDA for Sulopenem for Treatment of Uncomplicated Urinary Tract Infections
Published: 2020-09-30 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: 155.13%
H: 48.78%
C: -35.98%
positive fda sulopenem treatment injection infections
Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020
Published: 2020-10-19 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: 27.76%
H: 27.07%
C: 5.89%
phase 3 trial injection infections
UPDATE -- Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020
Published: 2020-10-19 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: 27.76%
H: 27.07%
C: 5.89%
phase 3 trial injection infections
Iterum Therapeutics Announces Pricing of $17.5 Million Upsized Public Offering
Published: 2020-10-23 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -46.32%
H: 10.33%
C: 3.0%
offering therapeutics publication
Iterum Therapeutics Reports Third Quarter 2020 Financial Results
Published: 2020-11-16 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -0.38%
H: 0.37%
C: -1.54%
results therapeutics
Iterum Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem
Published: 2020-11-30 (Crawled : 15:40) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -0.59%
H: 1.57%
C: -3.47%
food drug sulopenem new drug application
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.